MPM BioImpact — 2018 Investments

3 investments dated 2018 · listed companies and verified rows first · show all

Harpoon Therapeuticsharpoontx.com in 𝕏Series B · Nov 2018 · $45M

A research-intensive biopharmaceutical company that develops medicines and vaccines.

BiotechHealthtechSouth San Francisco, US

Luke Nathaniel Walker(Executive Officer)Julie Eastland(Executive Officer, Director)in

BoardRonald Hunt(Director)Mark Chin(Director)Alan Colowick(Director)Jonathan Drachman(Director)

Board seatPatrick BaeuerleLuke EvninPablo CagnoniDan Hicklin· per SEC Form D

Co-investorsK2 HealthVentures Ridgeback Capital Taiho Ventures, LLC Arix Bioscience Lilly Asia Ventures New Leaf Venture Partners +1 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Redona Therapeutics, Inc.Rekindle Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.